126 related articles for article (PubMed ID: 9510355)
21. Comparative flow cytometric deoxyribonucleic acid studies on exophytic tumor and random mucosal biopsies in untreated carcinoma of the bladder.
Norming U; Nyman CR; Tribukait B
J Urol; 1989 Dec; 142(6):1442-7. PubMed ID: 2585616
[TBL] [Abstract][Full Text] [Related]
22. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
[TBL] [Abstract][Full Text] [Related]
23. Nuclear deoxyribonucleic acid ploidy in squamous cell bladder cancer.
Winkler HZ; Nativ O; Hosaka Y; Farrow GM; Lieber MM
J Urol; 1989 Feb; 141(2):297-302. PubMed ID: 2913348
[TBL] [Abstract][Full Text] [Related]
24. Comparative histopathology and deoxyribonucleic acid flow cytometry of random mucosal biopsies in untreated bladder carcinoma.
Norming U; Nyman CR; Tribukait B
J Urol; 1991 Jun; 145(6):1164-8. PubMed ID: 2033685
[TBL] [Abstract][Full Text] [Related]
25. Ploidy and proliferation in human bladder tumors as measured by flow-cytofluorometric DNA-analysis and its relations to histopathology and cytology.
Tribukait B; Gustafson H; Esposti P
Cancer; 1979 May; 43(5):1742-51. PubMed ID: 445364
[TBL] [Abstract][Full Text] [Related]
26. The significance of ploidy and proliferation in the clinical and biological evaluation of bladder tumours: a study of 100 untreated cases.
Tribukait B; Gustafson H; Esposti PL
Br J Urol; 1982 Apr; 54(2):130-5. PubMed ID: 7082931
[TBL] [Abstract][Full Text] [Related]
27. Alterations affecting the p53 control pathway in bilharzial-related bladder cancer.
Osman I; Scher HI; Zhang ZF; Pellicer I; Hamza R; Eissa S; Khaled H; Cordon-Cardo C
Clin Cancer Res; 1997 Apr; 3(4):531-6. PubMed ID: 9815716
[TBL] [Abstract][Full Text] [Related]
28. [Flow cytometric analysis of the DNA content of the urinary bladder cancers--study on the DNA heterogeneity in bladder cancers].
Toyota K; Nagamori S; Kashiwagi A; Nonomura K; Koyanagi T
Nihon Hinyokika Gakkai Zasshi; 1995 Aug; 86(8):1353-9. PubMed ID: 7474619
[TBL] [Abstract][Full Text] [Related]
29. Flow-cytometric deoxyribonucleic acid analysis of the human bladder cancers with reference to histopathological findings.
Hamano K; Kinjo M; Kumazawa J
Eur Urol; 1992; 22(2):153-7. PubMed ID: 1478232
[TBL] [Abstract][Full Text] [Related]
30. [DNA ploidy and cell cycle phase analysis with flow cytometry in bladder wash. Preliminary experience].
Rivas del Fresno M; Salas Bustamante A; Suárez González JA; Tardón García A; Sampedro Nuño A
Arch Esp Urol; 2000; 53(1):29-36. PubMed ID: 10730422
[TBL] [Abstract][Full Text] [Related]
31. Flow cytometric DNA ploidy analysis in canine transitional cell carcinoma of urinary bladders.
Clemo FA; DeNicola DB; Carlton WW; Morrison WB; Walker E
Vet Pathol; 1994 Mar; 31(2):207-15. PubMed ID: 8203084
[TBL] [Abstract][Full Text] [Related]
32. Tumor biology in diagnostic cytology: DNA cytometry in carcinomas of the bladder and prostate.
Tribukait B
Recent Results Cancer Res; 1993; 133():23-31. PubMed ID: 8296068
[TBL] [Abstract][Full Text] [Related]
33. Deoxyribonucleic acid flow cytometry in invasive bladder carcinoma: a possible predictor for successful bladder preservation following transurethral surgery and chemotherapy-radiotherapy.
Hug EB; Donnelly SM; Shipley WU; Heney NM; Kaufman DS; Preffer FI; Schwartz SM; Colvin RB; Althausen AF
J Urol; 1992 Jul; 148(1):47-51. PubMed ID: 1613879
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.
Lanza G; Gafà R; Santini A; Maestri I; Dubini A; Gilli G; Cavazzini L
Cancer; 1998 Jan; 82(1):49-59. PubMed ID: 9428479
[TBL] [Abstract][Full Text] [Related]
35. DNA ploidy status: its impact on early-stage endometrial adenocarcinoma.
Goodman A; Bell DA; Rice LW
Gynecol Oncol; 1993 Dec; 51(3):355-61. PubMed ID: 8112645
[TBL] [Abstract][Full Text] [Related]
36. Origins and clinical implications of aneuploidy in early bladder cancer.
Shackney SE; Berg G; Simon SR; Cohen J; Amina S; Pommersheim W; Yakulis R; Wang S; Uhl M; Smith CA
Cytometry; 1995 Dec; 22(4):307-16. PubMed ID: 8749781
[TBL] [Abstract][Full Text] [Related]
37. Flow cytometric DNA analysis of poorly differentiated adenocarcinoma of the colorectum.
Taniyama K; Suzuki H; Matsumoto M; Hakamada K; Toyama K; Tahara E
Jpn J Clin Oncol; 1991 Dec; 21(6):406-11. PubMed ID: 1805045
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of bromodeoxyuridine high labeled bladder cancer measured by flow cytometry: does flow cytometric determination predict the prognosis of patients with transitional cell carcinoma of the bladder.
Tachibana M; Deguchi N; Baba S; Jitsukawa S; Hata M; Tazaki H
J Urol; 1993 Apr; 149(4):739-43. PubMed ID: 8455234
[TBL] [Abstract][Full Text] [Related]
39. Flow cytometric analysis of DNA abnormalities in colorectal carcinomas.
Bocquillon PG; Daver A; Page M; Dalifard I; Chassevent A; Cellier P; Bertrand G; Larra F; George P; Chabrun B
Bull Cancer; 1989; 76(3):291-300. PubMed ID: 2736315
[TBL] [Abstract][Full Text] [Related]
40. [The clinical significance of flow cytometric DNA measurement of paraffin specimen in bladder tumor].
Wang Z
Zhonghua Wai Ke Za Zhi; 1990 Aug; 28(8):505-8, 512. PubMed ID: 2086120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
